These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 26537623

  • 1. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
    Newland A, Godeau B, Priego V, Viallard JF, López Fernández MF, Orejudos A, Eisen M.
    Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
    [Abstract] [Full Text] [Related]

  • 2. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).
    Bussel JB, Hsieh L, Buchanan GR, Stine K, Kalpatthi R, Gnarra DJ, Ho RH, Nie K, Eisen M.
    Pediatr Blood Cancer; 2015 Feb; 62(2):208-213. PubMed ID: 25345874
    [Abstract] [Full Text] [Related]

  • 3. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
    Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M.
    Lancet; 2016 Jul 02; 388(10039):45-54. PubMed ID: 27103127
    [Abstract] [Full Text] [Related]

  • 4. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ.
    Clin Ther; 2009 Sep 02; 31(9):1887-907. PubMed ID: 19843480
    [Abstract] [Full Text] [Related]

  • 5. Romiplostim for the management of perioperative thrombocytopenia.
    Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ.
    Br J Haematol; 2018 Jul 02; 182(1):106-113. PubMed ID: 29767837
    [Abstract] [Full Text] [Related]

  • 6. Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.
    Shirasugi Y, Ando K, Miyazaki K, Tomiyama Y, Okamoto S, Kurokawa M, Kirito K, Yonemura Y, Mori S, Usuki K, Iwato K, Hashino S, Wei H, Lizambri R.
    Int J Hematol; 2011 Jul 02; 94(1):71-80. PubMed ID: 21706145
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia.
    Tarantino MD, Bussel JB, Blanchette VS, Beam D, Roy J, Despotovic J, Raj A, Carpenter N, Mehta B, Eisen M.
    Haematologica; 2019 Nov 02; 104(11):2283-2291. PubMed ID: 30846500
    [Abstract] [Full Text] [Related]

  • 8. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP, Heddle NM, Kelton JG, Hamilton K, Wang G, Sholapur N, Carruthers J, Hsia C, Blais N, Toltl L, Hamm C, Pearson MA, Arnold DM.
    Transfusion; 2016 Jan 02; 56(1):73-9. PubMed ID: 26400824
    [Abstract] [Full Text] [Related]

  • 9. A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
    Steurer M, Quittet P, Papadaki HA, Selleslag D, Viallard JF, Kaiafa G, Janssens A, Kozak T, Wadenvik H, Schoonen M, Belton L, Kreuzbauer G.
    Eur J Haematol; 2017 Feb 02; 98(2):112-120. PubMed ID: 27557853
    [Abstract] [Full Text] [Related]

  • 10. Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim.
    Bussel JB, Wang X, Lopez A, Eisen M.
    Hematology; 2016 May 02; 21(4):257-62. PubMed ID: 26251926
    [Abstract] [Full Text] [Related]

  • 11. Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice.
    Ptushkin VV, Vinogradova OY, Pankrashkina MM, Chernikov MV, Arshanskaya EG, Tkachenko NE.
    Ter Arkh; 2018 Aug 17; 90(7):70-76. PubMed ID: 30701925
    [Abstract] [Full Text] [Related]

  • 12. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist.
    LaMoreaux B, Barbar-Smiley F, Ardoin S, Madhoun H.
    Semin Arthritis Rheum; 2016 Feb 17; 45(4):e10-2. PubMed ID: 26329147
    [Abstract] [Full Text] [Related]

  • 13. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.
    Marquínez-Alonso I, Escudero-Vilaplana V, Pernía S, Beléndez Bieler C, Fernández-Llamazares CM, Sanjurjo-Sáez M.
    J Clin Pharm Ther; 2014 Aug 17; 39(4):376-82. PubMed ID: 24702274
    [Abstract] [Full Text] [Related]

  • 14. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
    Fenaux P, Muus P, Kantarjian H, Lyons RM, Larson RA, Sekeres MA, Becker PS, Orejudos A, Franklin J.
    Br J Haematol; 2017 Sep 17; 178(6):906-913. PubMed ID: 28616874
    [Abstract] [Full Text] [Related]

  • 15. Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.
    Kohn B, Bal G, Chirek A, Rehbein S, Salama A.
    BMC Vet Res; 2016 Jun 10; 12():96. PubMed ID: 27283401
    [Abstract] [Full Text] [Related]

  • 16. Romiplostim for the treatment of primary immune thrombocytopenia.
    Janssens A.
    Expert Rev Hematol; 2012 Apr 10; 5(2):133-44. PubMed ID: 22475281
    [Abstract] [Full Text] [Related]

  • 17. Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.
    Selleslag D, Bird R, Altomare I, Giagounidis A, Janssens A, Pabinger I, Pullarkat V, Wei H, Kreuzbauer G.
    Eur J Haematol; 2015 Feb 10; 94(2):169-76. PubMed ID: 25039799
    [Abstract] [Full Text] [Related]

  • 18. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.
    Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S.
    Br J Haematol; 2013 May 10; 161(3):411-23. PubMed ID: 23432528
    [Abstract] [Full Text] [Related]

  • 19. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R.
    Am J Hematol; 2016 May 10; 91(5):E293-5. PubMed ID: 26910388
    [Abstract] [Full Text] [Related]

  • 20. Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.
    Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.
    J Clin Pharm Ther; 2012 Dec 10; 37(6):729-32. PubMed ID: 22583038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.